• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶酸缺乏是帕金森病高同型半胱氨酸血症主要决定因素的证据。

Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

作者信息

dos Santos Eliseu Felippe, Busanello Estela Natacha Brandt, Miglioranza Anelise, Zanatta Angela, Barchak Alethea Gatto, Vargas Carmen Regla, Saute Jonas, Rosa Charles, Carrion Maria Júlia, Camargo Daiane, Dalbem André, da Costa Jaderson Costa, de Sousa Miguel Sandro René Pinto, de Mello Rieder Carlos Roberto, Wajner Moacir

机构信息

Universidade Luterana do Brasil, RS, Brazil.

出版信息

Metab Brain Dis. 2009 Jun;24(2):257-69. doi: 10.1007/s11011-009-9139-4. Epub 2009 Mar 18.

DOI:10.1007/s11011-009-9139-4
PMID:19294496
Abstract

In the present work we measured blood levels of total homocysteine ((t)Hcy), vitamin B(12) and folic acid in patients with Parkinson s disease (PD) and in age-matched controls and searched for possible associations between these levels with smoking, alcohol consumption, L-DOPA treatment and disease duration in PD patients. We initially observed that plasma (t)Hcy levels were increased by around 30 % in patients affected by PD compared to controls. Linear correlation, multiple regression and comparative analyses revealed that the major determinant of the increased plasma concentrations of (t)Hcy in PD patients was folic acid deficiency, whereas in controls (t)Hcy levels were mainly determined by plasma vitamin B(12) concentrations. We also observed that alcohol consumption, gender and L-DOPA treatment did not significantly alter plasma (t)Hcy, folic acid and vitamin B(12) levels in parkinsonians. Furthermore, disease duration was positively associated with (t)Hcy levels and smoking was linked with a deficit of folic acid in PD patients. Considering the potential synergistic deleterious effects of Hcy increase and folate deficiency on the central nervous system, we postulate that folic acid should be supplemented to patients affected by PD in order to normalize blood Hcy and folate levels, therefore potentially avoiding these risk factors for neurologic deterioration in this disorder.

摘要

在本研究中,我们测量了帕金森病(PD)患者及年龄匹配的对照组的总同型半胱氨酸((t)Hcy)、维生素B12和叶酸的血液水平,并探究这些水平与PD患者吸烟、饮酒、左旋多巴治疗及病程之间可能存在的关联。我们最初观察到,与对照组相比,PD患者的血浆(t)Hcy水平升高了约30%。线性相关、多元回归和比较分析显示,PD患者血浆(t)Hcy浓度升高的主要决定因素是叶酸缺乏,而在对照组中,(t)Hcy水平主要由血浆维生素B12浓度决定。我们还观察到,饮酒、性别和左旋多巴治疗并未显著改变帕金森病患者的血浆(t)Hcy、叶酸和维生素B12水平。此外,病程与(t)Hcy水平呈正相关,吸烟与PD患者叶酸缺乏有关。鉴于同型半胱氨酸升高和叶酸缺乏对中枢神经系统可能存在协同有害作用,我们推测应补充叶酸给PD患者,以使血液中的同型半胱氨酸和叶酸水平正常化,从而可能避免该疾病中导致神经功能恶化的这些风险因素。

相似文献

1
Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.叶酸缺乏是帕金森病高同型半胱氨酸血症主要决定因素的证据。
Metab Brain Dis. 2009 Jun;24(2):257-69. doi: 10.1007/s11011-009-9139-4. Epub 2009 Mar 18.
2
Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration.左旋多巴治疗的帕金森病患者高同型半胱氨酸血症:钴胺素和叶酸给药的影响
Eur J Neurol. 2005 May;12(5):365-8. doi: 10.1111/j.1468-1331.2004.00973.x.
3
Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients.左旋多巴治疗的帕金森病患者中的辅酶 Q10、高同型半胱氨酸血症和 MTHFR C677T 多态性。
Neuromolecular Med. 2012 Mar;14(1):84-90. doi: 10.1007/s12017-012-8174-1. Epub 2012 Feb 22.
4
Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.维生素 B12、叶酸和恩他卡朋对左旋多巴治疗的帕金森病患者同型半胱氨酸水平的影响:一项随机对照研究。
J Clin Neurosci. 2021 Jun;88:226-231. doi: 10.1016/j.jocn.2021.03.047. Epub 2021 Apr 20.
5
Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.左旋多巴和儿茶酚-O-甲基转移酶抑制剂对帕金森病患者血浆同型半胱氨酸的影响。
Mov Disord. 2005 Jan;20(1):69-72. doi: 10.1002/mds.20261.
6
Hyperhomocysteinaemia, low folate concentrations and MTHFR C677T mutation in abdominal aortic aneurysm.腹主动脉瘤患者的高同型半胱氨酸血症、低叶酸浓度及亚甲基四氢叶酸还原酶C677T突变
Vasa. 2014 May;43(3):181-8. doi: 10.1024/0301-1526/a000347.
7
Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status.左旋多巴对帕金森病患者血浆同型半胱氨酸的影响:与B族维生素状态的关系。
Neurology. 2003 Apr 8;60(7):1125-9. doi: 10.1212/01.wnl.0000055899.24594.8e.
8
Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications.帕金森病患者的血浆同型半胱氨酸水平:抗帕金森病药物的作用
Parkinsonism Relat Disord. 2005 Mar;11(2):131-3. doi: 10.1016/j.parkreldis.2004.07.008. Epub 2004 Dec 20.
9
Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency.叶酸或钴胺素缺乏所致高同型半胱氨酸血症患者血浆总同型半胱氨酸的动力学
Am J Clin Nutr. 1996 Feb;63(2):194-202. doi: 10.1093/ajcn/63.2.194.
10
Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.COMT、MTHFR 和 SLC19A1(RFC-1) 多态性与帕金森病患者同型半胱氨酸血水平和认知障碍的关联。
Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7.

引用本文的文献

1
Say hello to my little friend… micronutraceuticals in neuroenergetics, neuronal health, and neurodegenerative diseases.向我的小朋友问好……神经能量学、神经元健康和神经退行性疾病中的微量营养素。
Front Neurosci. 2025 Apr 23;19:1498655. doi: 10.3389/fnins.2025.1498655. eCollection 2025.
2
Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and Neurodegeneration.揭示叶酸依赖性一碳代谢在癌症和神经退行性疾病中的治疗潜力。
Int J Mol Sci. 2024 Aug 28;25(17):9339. doi: 10.3390/ijms25179339.
3
The Impact of the Dietary Intake of Vitamin B12, Folic Acid, and Vitamin D3 on Homocysteine Levels and the Health-Related Quality of Life of Levodopa-Treated Patients with Parkinson's Disease-A Pilot Study in Romania.

本文引用的文献

1
Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.帕金森病家族中的吸烟、咖啡因与非甾体抗炎药。
Arch Neurol. 2007 Apr;64(4):576-80. doi: 10.1001/archneur.64.4.576.
2
Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.血浆同型半胱氨酸水平与帕金森病:疾病进展、颈动脉内膜中层厚度及神经精神并发症
Clin Neuropharmacol. 2006 Nov-Dec;29(6):305-11. doi: 10.1097/01.WNF.0000236763.16032.60.
3
Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa.
维生素B12、叶酸和维生素D3的膳食摄入量对左旋多巴治疗的帕金森病患者同型半胱氨酸水平及健康相关生活质量的影响——罗马尼亚的一项初步研究
Diagnostics (Basel). 2024 Jul 26;14(15):1609. doi: 10.3390/diagnostics14151609.
4
The menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases.潜伏的威胁:细菌淀粉样蛋白作为自身免疫和神经退行性疾病的诱因。
Curr Opin Microbiol. 2024 Jun;79:102473. doi: 10.1016/j.mib.2024.102473. Epub 2024 Apr 11.
5
Exploring the complexities of 1C metabolism: implications in aging and neurodegenerative diseases.探索1C代谢的复杂性:对衰老和神经退行性疾病的影响。
Front Aging Neurosci. 2024 Jan 4;15:1322419. doi: 10.3389/fnagi.2023.1322419. eCollection 2023.
6
Association between the risk and severity of Parkinson's disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis.帕金森病的风险和严重程度与血浆同型半胱氨酸、维生素B12和叶酸水平之间的关联:一项系统评价和荟萃分析。
Front Aging Neurosci. 2023 Oct 24;15:1254824. doi: 10.3389/fnagi.2023.1254824. eCollection 2023.
7
The Role of Micronutrients in Neurological Disorders.微量营养素在神经紊乱中的作用。
Nutrients. 2023 Sep 25;15(19):4129. doi: 10.3390/nu15194129.
8
Metformin role in Parkinson's disease: a double-sword effect.二甲双胍在帕金森病中的作用:一把双刃剑。
Mol Cell Biochem. 2024 Apr;479(4):975-991. doi: 10.1007/s11010-023-04771-7. Epub 2023 Jun 2.
9
Sex Differences in the Level of Homocysteine in Alzheimer's Disease and Parkinson's Disease Patients: A Meta-Analysis.阿尔茨海默病和帕金森病患者同型半胱氨酸水平的性别差异:一项荟萃分析
Brain Sci. 2023 Jan 15;13(1):153. doi: 10.3390/brainsci13010153.
10
Local and systemic effects of microbiome-derived metabolites.微生物组衍生代谢物的局部和全身效应。
EMBO Rep. 2022 Oct 6;23(10):e55664. doi: 10.15252/embr.202255664. Epub 2022 Aug 29.
生活方式因素对接受左旋多巴治疗的帕金森病患者血浆同型半胱氨酸水平的作用。
Nutr Neurosci. 2006 Feb-Apr;9(1-2):11-6. doi: 10.1080/10284150600583446.
4
Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease.帕金森病患者的高同型半胱氨酸血症与亚甲基四氢叶酸还原酶多态性
Neurosci Lett. 2006 Aug 14;404(1-2):56-60. doi: 10.1016/j.neulet.2006.05.040. Epub 2006 Jun 19.
5
Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy.帕金森病患者(接受左旋多巴治疗和未接受左旋多巴治疗)的血清同型半胱氨酸水平及亚甲基四氢叶酸还原酶C677T基因型
J Neurol Sci. 2006 Oct 25;248(1-2):56-61. doi: 10.1016/j.jns.2006.05.040. Epub 2006 Jun 13.
6
The many facets of hyperhomocysteinemia: studies from the Framingham cohorts.高同型半胱氨酸血症的多方面研究:来自弗雷明汉队列的研究
J Nutr. 2006 Jun;136(6 Suppl):1726S-1730S. doi: 10.1093/jn/136.6.1726S.
7
Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia.神经退行性疾病中同型半胱氨酸神经毒性的机制,特别涉及痴呆症。
FEBS Lett. 2006 May 29;580(13):2994-3005. doi: 10.1016/j.febslet.2006.04.088. Epub 2006 May 6.
8
Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.同型半胱氨酸代谢、高同型半胱氨酸血症与血管疾病:综述
J Inherit Metab Dis. 2006 Feb;29(1):3-20. doi: 10.1007/s10545-006-0106-5.
9
Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study.同型半胱氨酸、维生素B-12、叶酸与老年人认知功能减退风险:莱顿85岁及以上人群研究
Am J Clin Nutr. 2005 Oct;82(4):866-71. doi: 10.1093/ajcn/82.4.866.
10
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.左旋多巴治疗的伴有认知功能障碍的帕金森病患者的血浆同型半胱氨酸水平
Clin Chem Lab Med. 2005;43(10):1107-10. doi: 10.1515/CCLM.2005.193.